200G non-GMP compound, N-(3-(2-OXOPYRROLIDIN-1-YL)propyl)-4-(6-phenylimidazo[1,5-a]pyrazin-3- YL)benzamide, greater than 95% purity by lcms and NMR.

Ended Purchase Order Awarded

Contract number
75N95023P00162
Awardee
Awarding agency
Obligated
$19,850

Award facts

Opportunity
Contract value 100% obligated
$19,850.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
NAICS code
325199 All Other Basic Organic Chemical Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Competed under SAP · 5 offers Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Rockville, MD 20850, USA

Award details come from SAM.gov/FPDS.

Quick answers

Who was awarded contract 75N95023P00162?

75N95023P00162 was awarded to Karebay Biochem Inc. by National Institute on Drug Abuse (National Institutes of Health) on April 10, 2023.

How much is contract 75N95023P00162 worth?

The government has obligated $19,850 on 75N95023P00162.

Which agency awarded contract 75N95023P00162?

National Institute on Drug Abuse (National Institutes of Health) awarded 75N95023P00162, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).

Was contract 75N95023P00162 competed?

The extent of competition for 75N95023P00162 was competed under sap. The government received 5 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login